Multiple Sclerosis - Biogen
As pioneers in neuroscience, Biogen has an innovative therapeutic pipeline that aims to reverse disability, repair damage, and address other remaining unmet needs in MS, with the goal of significantly altering the course of MS and preventing disease development and …
Official Patient Website | Tecfidera® (dimethyl fumarate)
Discover Tecfidera® (dimethyl fumarate), a twice-daily pill for relapsing MS. Learn about efficacy, and see important Safety Information.
Relapsing MS Pill Treatments - Biogen Options
VUMERITY is a prescription medicine used to treat people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.
FDA Approves First Biosimilar Drug for MS - Healthline
2023年8月28日 · The FDA approved Tyruko (natalizumab), a biosimilar to previously-approved Tysabri, as a treatment for relapsing forms of multiple sclerosis.
The Evolving Field of MS Research | Biogen
2024年9月19日 · For more than 25 years Biogen has been a leader in the research and development of new medications for multiple sclerosis (MS). Our understanding of the disease has significantly evolved over this time, especially in diagnosis and treatment options.
VUMERITY® (diroximel fumarate), an oral medication
VUMERITY is a prescription medicine used to treat people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults
Relapsing MS Infusion Treatment - Biogen Options
TYSABRI® (natalizumab) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TYSABRI increases the risk of progressive multifocal leukoencephalopathy (PML).
AVONEX® (interferon beta-1a) | Official Patient Site
Get the latest information about relapsing MS and AVONEX. Sign up to get a free brochure, our newsletters, and personalized support from Biogen Support Services.
Biogen Treatment Options for Relapsing MS
Biogen offers five approved treatments for relapsing MS. Learn more about each option to help you make an informed decision.
FDA approves Biogen's MS drug Plegridy | AP News - Associated …
2014年8月16日 · Multiple sclerosis is a disease of the immune system in which the body attacks the brain and spinal cord. Its symptoms can come and go, often reappearing months later. The European Commission recently approved Plegridy. Biogen also markets the multiple sclerosis drugs Avonex and Tysabri.